@FierceMedDev: Stryker confronts mounting metal hip recall lawsuits. Story | Follow @FierceMedDev
@DamianFierce: St. Jude is targeting FDA approval for its renal denervation device with a new study. Report | Follow @DamianFierce
@MarkHFierce: Get your FMD Fierce 15 nominations in today. | Follow @MarkHFierce
@MichaelGFierce: ICYMI yesterday: Medtronic triggers summer PMA process for drug-eluting balloon. Story | Follow @MichaelGFierce
> The FDA has assigned its most-serious Class I tag to Nephron Pharmaceuticals' recall of the EZ Breathe Atomizer. Note
> Edwards Lifesciences ($EW) received an FDA warning letter last month, and the agency disclosed its findings. Letter
> Rosetta Genomics ($ROSG) is more than doubling its U.S. sales reach for its recently rebranded Rosetta Cancer Origin Test. News
> Israeli startup OrCam has developed a device that can help the visually impaired read. Article
> AxoGen won Canadian regulatory approval for two new nerve regeneration devices. Item
> A breast implant after mastectomy doesn't threaten a woman's chance of survival, new research from the Northern California Cancer Center suggests. Item
> Soaring breast cancer rates in emerging markets is boosting demand for screening equipment, the research and consulting firm GlobalData concludes in a new analysis. Item
Biotech News
@FierceBiotech: Trending: Top 10 experimental cancer drugs - 2013. Special report | Follow @FierceBiotech
@JohnCFierce: Web traffic at Fierce Life Sciences hit 778,789 in May, 1.6 million PVs. Subscriber openers around 82,000 a day now on reports. All records. | Follow @JohnCFierce
@RyanMFierce: J&J backs $biotech startup Protagonist in $14M financing. News | Follow @RyanMFierce
> FDA clamps clinical hold on Pluristem PhII stem cell trial. News
> R&D: Are true drug breakthroughs a thing of the past? More
> AstraZeneca tosses another PhIII failure onto the scrap heap. Report
> Akebia snags $41M financing in anemia-drug race with GlaxoSmithKline, others. Article
> Cardio3 tests Europe's appetite for biotech IPOs. Item
Pharma News
@FiercePharma: FDA close to resolving all cancer drug shortages; most stem from production halts to fix manufacturing issues. More | Follow @FiercePharma
@EricPFierce: ICYMI: Dr. Reddy's, Fujifilm pull plug on Japanese joint venture. Article | Follow @EricPFierce
@CarlyHFierce: European Commission to crack down on 'pay for delay,' reportedly fine 9 companies including Lundbeck, Merck KGaA, Ranbaxy. Article | Follow @CarlyHFierce
> J&J recalls millions of contraceptives as problems pile up. More
> Limited track-and-trace moves forward in U.S. Story
> Bristol-Myers' Abilify coupons prevail in health-plan lawsuit. Article
Biotech Research News
@EmilyMFierce: Alterations in one gene may drive allergic, autoimmune diseases. Story | Follow @EmilyMFierce
> $750,000 in grants available to scientific researchers under new program. Report
> NIH lays out effects of sequestration on biomedical research. News
> New agent stops replication of hep C virus in preclinical studies. Article
> Pfizer taps UCSF for small-molecule drug discovery. Story
Pharma Manufacturing News
> CorePharma gets closeout letter for NJ plant. Report
> WSJ: Novartis looks to unload CMO LTS Lohmann. Article
> FDA close to resolving all cancer drug shortages. Story
> Explosion, fire at Teva plant kills one, injures 30. More